BackAbeona Therapeutics Overview

Abeona Therapeutics Cost of Revenue

Cost of Revenue analysis for ABEO.

Quarterly Cost of Revenue

$3.56M

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$7.85M
371.09% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)